Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Lancet. Psychiatry|August 8, 2016
Efficacy and cost-effectiveness of a specialist depression service versus usual specialist mental health care to manage persistent depression: a randomised controlled trialRichard Morriss, Anne Garland, Neil Nixon, et al.JMIR Research Protocols|May 26, 2025
Mindfulness-Based Cognitive Therapy for Life (MBCT-L) Versus Stress Reduction Psychoeducation (SRP) for the Improvement of Mental Well-Being in Health Care and Other Public Sector Staff: Protocol for the Well at Work Randomized Controlled TrialElena Nixon, Shireen Patel, Priya Patel, et al.Trials|February 20, 2025
Opportunities and challenges to delivering a trial for depressive symptoms in primary care during the COVID-19 pandemic: insights from the Alpha-Stim-D randomised controlled trialShireen Patel, Priya Patel, Clement Boutry, et al.Trials|April 5, 2022
A randomised controlled trial investigating the clinical and cost-effectiveness of Alpha-Stim AID cranial electrotherapy stimulation (CES) in patients seeking treatment for moderate severity depression in primary care (Alpha-Stim-D Trial)Shireen Patel, Clement Boutry, Priya Patel, et al.The Lancet Regional Health. Europe|December 3, 2025
Cost-effectiveness of pramipexole augmentation for acute phase and maintenance therapy of treatment-resistant depression compared to placebo augmentation: economic evaluation of the PAX-D randomised controlled trialAgata Łaszewska, Timea Helter, Ashley Baldwin, et al.The Lancet. Psychiatry|February 1, 2023
Clinical effectiveness of active Alpha-Stim AID versus sham Alpha-Stim AID in major depression in primary care in England (Alpha-Stim-D): a multicentre, parallel group, double-blind, randomised controlled trialRichard Morriss, Shireen Patel, Clement Boutry, et al.Eclinicalmedicine|September 9, 2024
A systematic review and network meta-analysis of psychological, psychosocial, pharmacological, physical and combined treatments for adults with a new episode of depressionIfigeneia Mavranezouli, Odette Megnin-Viggars, Hugo Pedder, et al.BMJ Open|May 27, 2021
Changes in daily mental health service use and mortality at the commencement and lifting of COVID-19 'lockdown' policy in 10 UK sites: a regression discontinuity in time designIoannis Bakolis, Robert Stewart, David Baldwin, et al.BMJ Open|March 19, 2026
Open-label randomised controlled trial of aripiprazole/sertraline combination in comparison with quetiapine for the clinical and cost-effectiveness of treatment of bipolar depression (the ASCEnD study): study protocolLumbini Azim, Sarah Al-Ashmori, Chrissie Butcher, et al.The Lancet. Psychiatry|July 2, 2025
Pramipexole augmentation for the acute phase of treatment-resistant, unipolar depression: a placebo-controlled, double-blind, randomised trial in the UKMichael Browning, Philip J Cowen, Ushma Galal, et al.Pageof 2